Find and Pitch Jounalists, Get Your Story Covered

Tags: hardware robotics startups funding industrial robotics

	Profile	Recent Articles on Subject
1	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: The end of 23andMe’s drug discovery dream - 3 days ago
2	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - 3 days ago STAT+: Up and down the ladder: The latest comings and goings - 6 days ago STAT+: Up and down the ladder: The latest comings and goings - 13 days ago STAT+: Up and down the ladder: The latest comings and goings - 20 days ago STAT+: Up and down the ladder: The latest comings and goings - 27 days ago STAT+: Up and down the ladder: The latest comings and goings - 2 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Pharmalittle: We’re reading about BIO cutting ties with WuXi, EU pharma rules, and more - 8 months ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - 12 months ago STAT+: Pharmalittle: Life sciences deals on track to hit lowest point since 2017; EU regulators order Illumina to divest Grail - about 1 year ago
3	Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. medical reportingnews	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 6 days ago
4	Sarah Owermohle STAT News Health reporter @STATNews. Covers Biden's agenda. Washington, District of Columbia health policyjournalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 6 days ago
5	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 6 days ago
6	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	2024 PharmaVoice 100s: Trailblazers - 29 days ago California is a life sciences leader. Joe Panetta has been one of its most vocal advocates. - about 1 month ago
7	STAT Staff STAT News Frontiers of health & medicine reporting. healthmedicinejournalism	WuXi looks to sell assets as BIOSECURE Act looms - about 1 month ago
8	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Lilly lays down $1B to be ‘first in biology’ with obesity gene therapies - 2 months ago 4 offbeat biotechs making a splash in the life sciences - 7 months ago
9	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Element Biosciences raises another massive round - 4 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 6 months ago How resurrecting extinct species might impact medicine - 7 months ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - 11 months ago Novartis is building a new radioligand plant in China - 12 months ago
10	Katrina Krämer Nature Science journalist. Cambridge, UK science journalismchemistry	Daily briefing: How this lab became one of the most successful in the world - 5 months ago

Journalists covering Life sciences industry